
Free
In-App Purchases
About
PlasmaBind VPA is an educational pharmacokinetic simulation tool designed to explore valproic acid exposure in adult patients.
The app simulates both total and estimated free valproic acid concentrations using an albumin-aware model. It incorporates practical clinical factors such as protein binding, formulation differences, hepatic function, and selected drug interaction presets.
Terms of Use (EULA): https://www.apple.com/legal/internet-services/itunes/dev/stdeula/
Privacy Policy: https://plasmabind.ca/privacy
Key features:
• Simulation of total and estimated free valproic acid concentrations
• Albumin-based free fraction estimation with concentration-dependent effects
• Visualization of concentration-time profiles
• Interaction presets (e.g., carbapenems, enzyme inducers, aspirin)
• Hepatic function and food effect adjustments
• Unit conversion (SI and conventional)
This app is intended for educational and research purposes only.
Important:
PlasmaBind VPA is not a medical device and does not provide dosing recommendations. It should not be used for clinical decision-making. Always interpret results alongside measured drug levels, patient assessment, and local clinical guidance.
Adult use only (not intended for patients under 18 years).
Show more
What's New in PlasmaBind Valproic
Version: 1.0.4
April 9, 2026
Introduced subscription-based access (PlasmaBind Pro). Added secure in-app purchase functionality to unlock advanced pharmacokinetic simulation features. Improved stability and performance.
MoreSubscription plans
PlasmaBind Pro
Unlock advanced pharmacokinetic simulations
$9.991 Year






